ES2075423T5 - Una composicion sustitutiva del tabaco. - Google Patents

Una composicion sustitutiva del tabaco.

Info

Publication number
ES2075423T5
ES2075423T5 ES91901499T ES91901499T ES2075423T5 ES 2075423 T5 ES2075423 T5 ES 2075423T5 ES 91901499 T ES91901499 T ES 91901499T ES 91901499 T ES91901499 T ES 91901499T ES 2075423 T5 ES2075423 T5 ES 2075423T5
Authority
ES
Spain
Prior art keywords
tobacco
substitute composition
composition
substitute
cyclodexstrincompound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901499T
Other languages
English (en)
Other versions
ES2075423T3 (es
Inventor
Thommy Carlsson
Sven Borje Andersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377819&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2075423(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of ES2075423T3 publication Critical patent/ES2075423T3/es
Publication of ES2075423T5 publication Critical patent/ES2075423T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cigarettes, Filters, And Manufacturing Of Filters (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SUCEDANEO DEL TABACO LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION SUCEDANEA DEL TABACO EN DONDE LA NICOTINA PRESENTA LA FORMA DE UN COMPLEJO DE INCLUSION ENTRE LA NICOTINA Y UN COMPUESTO DE CICLODEXTRINA.
ES91901499T 1989-12-21 1990-12-18 Una composicion sustitutiva del tabaco. Expired - Lifetime ES2075423T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904295A SE8904295D0 (sv) 1989-12-21 1989-12-21 Smoking substitute

Publications (2)

Publication Number Publication Date
ES2075423T3 ES2075423T3 (es) 1995-10-01
ES2075423T5 true ES2075423T5 (es) 2000-05-16

Family

ID=20377819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901499T Expired - Lifetime ES2075423T5 (es) 1989-12-21 1990-12-18 Una composicion sustitutiva del tabaco.

Country Status (10)

Country Link
EP (1) EP0506774B2 (es)
JP (1) JP3210945B2 (es)
AT (1) ATE125705T1 (es)
AU (1) AU6977491A (es)
DE (1) DE69021396T3 (es)
DK (1) DK0506774T4 (es)
ES (1) ES2075423T5 (es)
GR (2) GR3017486T3 (es)
SE (1) SE8904295D0 (es)
WO (1) WO1991009599A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
SE9002052D0 (sv) * 1990-06-08 1990-06-08 Pharmacia Ab Smoking composition
WO1994022445A2 (en) * 1993-03-26 1994-10-13 Merkus Franciscus W H M Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AU717600B2 (en) * 1993-07-26 2000-03-30 Mcneil Ab Improved nicotine lozenge and therapeutic method for smoking cessation
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
DK0906089T3 (da) 1996-05-13 2003-12-08 Novartis Consumer Health Sa Mundafgivelsessystem
US6166032A (en) * 1997-02-07 2000-12-26 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6211194B1 (en) 1998-04-30 2001-04-03 Duke University Solution containing nicotine
ES2285233T3 (es) * 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
CN100584385C (zh) * 2003-07-10 2010-01-27 协和发酵生化株式会社 片剂及其制备方法
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP5215175B2 (ja) * 2005-05-25 2013-06-19 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US20070267033A1 (en) 2006-02-09 2007-11-22 Philip Morris Usa Inc. Gamma cyclodextrin flavoring-release additives
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
PT2177213E (pt) * 2008-09-17 2013-02-21 Siegfried Ltd Granulado contendo nicotina
PT2361081T (pt) * 2008-10-14 2016-09-05 Mcneil Ab Forma de dosagem intra-oral multiporção e seu uso
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
WO2024097549A1 (en) * 2022-11-03 2024-05-10 Nic Nac Naturals, Llc Composition and method for controlled human nicotine absorption without ph adjusters

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
JPS5312600B2 (es) * 1974-06-21 1978-05-02
GB2142822B (en) * 1983-06-29 1987-02-11 Alec Stanley Walter Shaw Nicotine lozenges
IL73912A0 (en) * 1984-01-09 1985-03-31 Advanced Tobacco Prod Nicotine preparation
FR2608156B1 (fr) * 1986-12-12 1988-12-30 Ethypharm Sa Chewing-gum pour se liberer du tabac

Also Published As

Publication number Publication date
DE69021396T3 (de) 2000-08-31
ATE125705T1 (de) 1995-08-15
GR3033405T3 (en) 2000-09-29
AU6977491A (en) 1991-07-24
EP0506774B1 (en) 1995-08-02
DK0506774T4 (da) 2000-12-04
JPH05504949A (ja) 1993-07-29
SE8904295D0 (sv) 1989-12-21
DK0506774T3 (da) 1995-11-13
DE69021396D1 (de) 1995-09-07
DE69021396T2 (de) 1996-04-04
EP0506774B2 (en) 2000-03-22
ES2075423T3 (es) 1995-10-01
JP3210945B2 (ja) 2001-09-25
WO1991009599A1 (en) 1991-07-11
EP0506774A1 (en) 1992-10-07
GR3017486T3 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
ES2075423T5 (es) Una composicion sustitutiva del tabaco.
SE8304966D0 (sv) Oral komposition
FI900381A0 (fi) Foerbaettringar till tobaksprodukter.
SE8803081D0 (sv) Improvements relating to smoking articles
SE8803082D0 (sv) Improvements relating to smoking articles
DK69488A (da) Cigaret
FI925552A (fi) Nikotin-ogenomslaepplig behaollare och dess framstaellningsfoerfarande
IT1226240B (it) Procedimento e disposizione per il trattamento del tabacco verde.
BR8304191A (pt) Aparelho e processo de formar uma haste de material de fumar e cigarro
IT1226242B (it) Procedimento e disposizione per il trattamento del tabacco verde.
AR222255A1 (es) Tabaco de fumar
FR2615752B1 (fr) Fabrication de filtres de fumee de tabac
ES2100871T5 (es) Mejoras relacionadas con articulos para fumar.
EA200101193A1 (ru) Сигарета с табачным фильтром
FR2632496B1 (fr) Cigares et cigarillos a tabac blond
FR2659532B3 (fr) Destructeur de megots de cigarettes ou de cigares.
BR6702382U (pt) Cigarro artificial,inibidor de vicio de fumar
FR2565824B1 (fr) Composition d'ambiance, frenatrice de l'envie de fumer du tabac
IT216196Z2 (it) Bocchino da fumo per sigari e sigarette ed inserto parafuoco e portafiltro dello stesso.
IT8164501A0 (it) Spegnimento rapido, inodoro, di mozziconi di sigaro e sigaretta.
GEP19960658B (en) Smoking article
OA09461A (fr) "Mélange de tabacs pour cigarette, et cigarette le comportant".
ES294143U (es) Protector para la caida de la ceniza de cigarros y cigarrillos
IT8302110A0 (it) Pinza per fumare sigari e sigarette
IT8884126A0 (it) Procedimento di espansione del trinciato di lamina di tabacco.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506774

Country of ref document: ES